TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 31 filers reported holding TELA BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,489,186 | +35.0% | 390,364 | 0.0% | 0.09% | +19.5% |
| Q3 2022 | $3,326,000 | -53.4% | 390,364 | -61.6% | 0.08% | -58.2% |
| Q2 2022 | $7,133,000 | -39.7% | 1,017,546 | 0.0% | 0.18% | -24.9% |
| Q1 2022 | $11,834,000 | -33.9% | 1,017,546 | -27.3% | 0.24% | -6.5% |
| Q4 2021 | $17,916,000 | -5.8% | 1,399,686 | +0.6% | 0.26% | -8.7% |
| Q3 2021 | $19,010,000 | -15.3% | 1,391,619 | -0.1% | 0.29% | -15.1% |
| Q2 2021 | $22,432,000 | +8.9% | 1,392,434 | +0.7% | 0.34% | +5.0% |
| Q1 2021 | $20,597,000 | -1.0% | 1,382,343 | -0.1% | 0.32% | -7.7% |
| Q4 2020 | $20,813,000 | -8.7% | 1,383,816 | +0.4% | 0.35% | -36.4% |
| Q3 2020 | $22,805,000 | +29.0% | 1,378,776 | +1.1% | 0.55% | +10.5% |
| Q2 2020 | $17,682,000 | +98.5% | 1,364,358 | +19.7% | 0.50% | +29.4% |
| Q1 2020 | $8,910,000 | -39.6% | 1,139,358 | 0.0% | 0.38% | -31.1% |
| Q4 2019 | $14,755,000 | – | 1,139,358 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,475,293 | $22,188,000 | 5.76% |
| Opaleye Management Inc. | 365,000 | $5,490,000 | 0.72% |
| COWEN AND COMPANY, LLC | 401,776 | $6,043,000 | 0.54% |
| Orbimed Advisors | 3,027,542 | $45,534,000 | 0.40% |
| SANDERS MORRIS HARRIS LLC | 113,418 | $1,705,000 | 0.39% |
| RTW INVESTMENTS, LP | 1,383,816 | $20,813,000 | 0.35% |
| PURA VIDA INVESTMENTS, LLC | 309,323 | $4,652,000 | 0.17% |
| ARMISTICE CAPITAL, LLC | 256,000 | $3,850,000 | 0.13% |
| PERKINS CAPITAL MANAGEMENT INC | 11,000 | $165,000 | 0.11% |
| Rossmore Private Capital | 34,484 | $519,000 | 0.10% |